Women executives, professionals, influencers, solution providers, government organizations, investors, and those interested or involved in the pharma, biotech, medical device, and other healthcare systems, are invited to attend the 12th Advancing Women’s Leadership Skills & Opportunities in Pharma & Healthcare conference being held at the Hotel Tampa Riverwalk from March 25-27, 2024, in Tampa, FL.
As women expand their leadership roles to move up in their career paths, this summit offers them an important platform to seek and impart knowledge. They can connect with industry peers and leaders for meaningful connections. Top women pharmaceutical and biotechnology professionals will share their…
To know more, please visit (https://nnw.fm/BjcPn)
About InvestorWire
InvestorWire (“IW”) is a specialized communications platform with a focus on advanced wire-grade press release syndication for private and public companies and the investment community. It is one of 60+ brands within the Dynamic Brand Portfolio @ IBN that delivers: (1) access to a vast network of wire solutions via InvestorWire to efficiently and effectively reach a myriad of target markets, demographics and diverse industries; (2) article and editorial syndication to 5,000+ outlets; (3) enhanced press release enhancement to ensure maximum impact; (4) social media distribution via IBN to millions of social media followers; and (5) a full array of tailored corporate communications solutions. With broad reach and a seasoned team of contributing journalists and writers, IW is uniquely positioned to best serve private and public companies that want to reach a wide audience of investors, influencers, consumers, journalists and the general public. By cutting through the overload of information in today’s market, IW brings its clients unparalleled recognition and brand awareness. IW is where breaking news, insightful content and actionable information converge.
For more information, please visit https://www.InvestorWire.com
Please see full terms of use and disclaimers on the InvestorWire website applicable to all content provided by IW, wherever published or re-published: https://www.InvestorWire.com/Disclaimer
InvestorWire
Los Angeles, CA
www.InvestorWire.com
310.299.1717 Office
Editor@InvestorWire.com
InvestorWire is powered by IBN